GlassScriptPhysician profile
Grace Isaacs
NPI 1538512967
$27,569.29
in general payments reported to CMS, 2019-2025
16 companies · $4,847 in 2025
The $4,847 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,541 · 2022: $7,888 · 2023: $4,542 · 2024: $3,750 · 2025: $4,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,185 · Food and Beverage: $2,801 · Travel and Lodging: $2,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,185.00 |
| Food and Beverage | $2,800.77 |
| Travel and Lodging | $2,154.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $22,652.64 | 2021-2025 | |
| Inspire Medical Systems, INC. | $1,966.91 | 2021-2025 | Inspire |
| Genzyme Corporation | $872.66 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $782.64 | 2021-2025 | Dupixent |
| Hologic Sales and Service, LLC | $209.34 | 2022 | |
| Stryker Corporation | $172.01 | 2021-2022 | |
| Glaxosmithkline, LLC. | $155.60 | 2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $145.27 | 2021-2022 | |
| Medtronic, INC. | $142.38 | 2021-2023 | Propel |
| Biohaven Pharmaceutical Holding Company LTD. | $119.18 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $100.07 | 2023 | Caldolor |
| Axsome Therapeutics, INC. | $94.01 | 2023 | Sunosi |
| Lucid Diagnostics INC. | $91.82 | 2022 | |
| Sanofi-Aventis U.S. LLC | $30.68 | 2021 | |
| Octapharma USA, INC. | $18.36 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $15.72 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Isaacs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.